Head to Head Contrast: CareFusion (CFN) vs. Its Competitors

CareFusion (NYSE: CFN) is one of 79 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its rivals? We will compare CareFusion to related companies based on the strength of its dividends, valuation, earnings, profitability, risk, institutional ownership and analyst recommendations.

Profitability

This table compares CareFusion and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CareFusion 16.18% 12.80% 7.62%
CareFusion Competitors -453.49% -35.39% -15.47%

Analyst Recommendations

This is a summary of current recommendations and price targets for CareFusion and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareFusion 0 0 0 0 N/A
CareFusion Competitors 271 1308 2767 98 2.61

As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 5.56%. Given CareFusion’s rivals higher possible upside, analysts plainly believe CareFusion has less favorable growth aspects than its rivals.

Earnings & Valuation

This table compares CareFusion and its rivals revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CareFusion N/A N/A 25.51
CareFusion Competitors $985.94 million $121.41 million 257.22

CareFusion’s rivals have higher revenue and earnings than CareFusion. CareFusion is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

65.4% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by institutional investors. 12.4% of shares of all “Medical Equipment, Supplies & Distribution” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

CareFusion rivals beat CareFusion on 5 of the 8 factors compared.

About CareFusion

CareFusion Corporation is a global medical technology company. The Company operates in two business segments: Medical Systems and Procedural Solutions. The Company’s primary product brands include: Alaris intravenous (IV) infusion systems; Pyxis and Rowa automated medication dispensing and supply management systems; AVEA, Vela and LTV Series respiratory ventilators; ChloraPrep skin antiseptic products; MaxGuard, MaxPlus, MaxZero, SmartSite and Texium needle-free IV infusion valves, administration sets and accessories; V. Mueller and Snowden-Pencer open surgical and laparoscopic instrumentation; PleurX, Achieve and Temno interventional specialty products; AirLife disposable ventilator circuits and oxygen masks used for providing respiratory therapy; Vital Signs single-use consumables for respiratory care and anesthesiology; Jaeger and SensorMedics cardiopulmonary diagnostic equipment, and MedMined data mining surveillance software and analytics.

Receive News & Ratings for CareFusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareFusion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply